Treatments & Interventions
Streptozocin
substance
Interferon alfacon-1
substance
Interferon gamma-1b
substance
Capecitabine
substance
Interferon alfa-2a
substance
Interferon alfa-2b
substance
Aldesleukin
substance
Mitomycin
substance
Floxuridine
substance
Oxaliplatin
substance
Peginterferon alfa-2b
substance
Bevacizumab
substance
Peginterferon alfa-2a
substance
Panitumumab
substance
Regorafenib
substance
Ramucirumab
substance
Tipiracil
substance
Tipiracil hydrochloride
substance
Related Conditions
Benign neoplasm of large intestine(child)
Carcinoma in situ of large intestine(child)
Neoplasm of uncertain behavior of large intestine(child)
Neoplasm of appendix(child)
Malignant tumour of large intestine(child)
Gastrointestinal stromal tumor of large intestine(child)
High grade glandular intraepithelial neoplasia of large intestine(child)
Neoplasm of cecum and/or colon and/or rectum(child)
Primary malignant neuroendocrine neoplasm of large intestine(child)
Neoplasm of intestinal tract(parent)
Disorder of large intestine(parent)
Quick Facts
- SNOMED CT
- 126837005
- UMLS CUI
- C0009404
- Fully Specified Name
- Neoplasm of large intestine (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 18
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.